Melatonin: A regulator of the interplay between FoxO1, miR96, and miR215 signaling to diminish the growth, survival, and metastasis of murine adenocarcinoma
In conclusion, this study sheds the light on M./P53/miR215/CD44 with an emphasis on M./miR96//foxO1 signaling cascades, as a novel pathway of melatonin signaling in adenocarcinoma to diminish cancer cell growth, survival and metastasis.
Source: BioFactors - Category: Biochemistry Authors: Rehab T. Oshiba,
Ehab Touson,
Yasser M. Elsherbini,
Mohamed E. Abdraboh Tags: Research Communication Source Type: research
More News: Adenocarcinoma | Biochemistry | Breast Cancer | Cancer | Cancer & Oncology | Hormones | Melatonin | Study